CPT code 88741 represents a quantitative transcutaneous procedure to evaluate methemoglobin levels through the skin. This noninvasive monitoring test has clinical relevance for detecting and managing methemoglobinemia, a condition that can impair oxygen delivery and may be encountered in emergency, inpatient, and outpatient settings. Nationally, standardized reporting and correct use of this code support clinical tracking, billing consistency, and appropriate utilization of noninvasive hemoglobin variant testing.

Key payers covered in this publication include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for transcutaneous methemoglobin measurement, guidance on typical sites of service, and operational notes such as the one-per-day reporting limitation. The report summarizes common modifiers and payer patterns where available and highlights implications for coding accuracy and claims processing. Where specific payer policy details, taxonomies, or diagnosis mappings are not provided in the input, the publication notes that those data elements are not available.

This piece is intended for coding professionals, clinical laboratory managers, and revenue cycle staff seeking a concise, national-level reference on CPT code 88741, its clinical purpose, and the key administrative considerations for documentation and daily reporting.